Table 2 Clinical characteristics

n (%)

Mean±SD

n (%)

No. of patients

238,639 (100)

5.57±5.28

58.72±11.69

7.85±1.72

75,829 (31.78)

BMI

<24 kg/m²

110,283 (46.21)

5.44±5.26

58.43±11.73

7.85±1.79

36,507 (33.10)

≥24 kg/m²

128,356 (53.79)

5.67±5.29

58.98±11.66

7.86±1.67

39,322 (30.64)

P value

<0.0001

<0.0001

0.2848

<0.0001

Treatment regimen

OAD only

157,212 (65.88)

4.76±4.65

58.16±11.52

7.67±1.58

54,438 (34.63)

1 OAD

58,028 (24.32)

4.38±4.95

57.45±12.08

7.65±1.69

21,834 (37.63)

2 OADs

80,113 (33.57)

4.74±4.34

58.35±11.21

7.66±1.53

26,942 (33.63)

≥3 OADs

19,071 (7.99)

6.01±4.71

59.56±10.89

7.75±1.49

5662 (29.69)

P value

<0.0001

<0.0001

<0.0001

<0.0001

OAD + insulin

80,973 (33.93)

7.12±6.04

59.85±11.92

8.21±1.91

21,227 (26.21)

Prandial

6243 (2.62)

6.30±5.91

58.83±12.49

8.14±2.06

1745 (27.95)

Basal

13,816 (5.79)

6.58±5.54

59.13±11.97

7.99±1.81

4251 (30.77)

Premixes

53,122 (22.26)

7.20±6.02

60.24±11.66

8.18±1.86

13,787 (25.95)

Basal-bolus

6411 (2.69)

8.12±6.87

58.90±13.02

8.89±2.25

1143 (17.83)

Others

1381 (0.58)

8.70±6.75

60.70±12.57

8.45±2.00

301 (21.80)

P value

<0.0001

<0.0001

<0.0001

<0.0001

OAD + GLP-1 RA

454 (0.19)

5.39±4.46

53.12±12.90

7.80±1.76

164 (36.12)

P value^a

<0.0001

<0.0001

<0.0001

<0.0001

SMBG

Yes

90,557 (37.95)

5.86±5.25

58.96±11.46

7.68±1.62

31,979 (35.31)

No

148,082 (62.05)

5.39±5.29

58.58±11.83

7.96±1.77

43,850 (29.61)

P value

<0.0001

<0.0001

<0.0001

<0.0001

Concomitant disease/complications

Yes

124,182 (52.04)

6.82±5.70

61.13±11.36

7.95±1.77

36,947 (29.75)

No

81,405 (34.11)

4.09±4.39

55.30±11.38

7.71±1.69

29,254 (35.94)

Don’t know

33,052 (13.85)

4.47±4.39

58.09±11.48

7.82±1.58

9,628 (29.13)

P value

<0.0001

<0.0001

<0.0001

<0.0001